Forte Biosciences, Inc. Annual Operating Income (Loss) in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Forte Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2023.
  • Forte Biosciences, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$12.8M, a 41.9% decline year-over-year.
  • Forte Biosciences, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$37.2M, a 53.5% decline year-over-year.
  • Forte Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$32.5M, a 134% decline from 2022.
  • Forte Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$13.9M, a 35.3% increase from 2021.
  • Forte Biosciences, Inc. annual Operating Income (Loss) for 2021 was -$21.5M, a 53.6% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$32.5M -$18.6M -134% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-18
2022 -$13.9M +$7.59M +35.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 -$21.5M +$24.8M +53.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$46.3M -$42.2M -1039% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$4.06M +$41.8M +91.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-16
2018 -$45.9M -$8.23M -21.9% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 -$37.6M -$5.94M -18.7% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 -$31.7M -$8.74M -38.1% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 -$23M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.